Resources

Type of publications
Regions
Diseases

5192 results found

2025 ∙ Ramrakhiani, H. Le, M. H. Kam, L. Nguyen, B. Yeo, Y. H. Levesley, C. R. Gudapati, S. Barnett, S. Cheung, R. Nguyen, M. H.

Long-Term Immunity and Anamnestic Response Following Hepatitis B Vaccination: A Systematic Review and Meta-Analysis

  • Newborn
  • Children
  • Adolescents
  • Adults
  • Hepatitis B
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Lamichhane, R. Pathak, I. D. Pathak, B. D. Adhikari, P. Dawadi, S. Rai, A. Ojha, P. Maharjan, K. Gautam, K. Dhakal, N. Saha, M.

Low Hepatitis B vaccination rates among medical students in South Asia: A systematic review and meta-analysis

  • South-East Asia
  • Eastern Mediterranean
  • India
  • Nepal
  • Pakistan
  • Bangladesh
  • All age groups
  • Hepatitis B
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Torres-Torres, J. Rojas-Zepeda, L. Villafan-Bernal, J. R. Martinez-Portilla, R. Espino-y-Sosa, S. Cerda-Flores, P. Moreno-Verduzco, E. R. Monroy-Munoz, I. E. Gonzalez-Guerrero, A. Y. Solis-Paredes, J. M. Duran, J. P.

Maternal RSV vaccination for infant protection: A systematic review and meta-analysis of phase 3 trials with an integrated economic evaluation

  • Pregnant women
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
  • Economic aspects
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Saad, K. Alomari, O. Dizdarogullari, G. E. Mokresh, M. E. Hussein, W. M. Eyvazova, H. Kaplan, O. Ghahremanpour, G. K. Hamam, M. Api, M. Elgenidi, A. Elhoufey, A. Hassan, A. M. Temsah, M. H. Ahmad, A. R. Alnusayri, A. Abdel-Sadek, Z. M. ElAshry, A. Alhasan, K. A. Abo-Elela, M. G. M.

Maternal RSV vaccine: a systematic review and meta-analysis of immunogenicity and perinatal safety

  • Pregnant women
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Alemayehu, A. Tefera, S.

Measles second dose vaccination coverage and associated factors in Ethiopia: A systematic review and meta-analysis

  • Africa
  • Ethiopia
  • Children
  • Measles
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Mustafa, M. Reznik, A. S. Uribe, J. Mintz, J. Taldone, S. Shukla, B. Raja, M. Natori, Y.

Measles seropositivity in previously vaccinated individuals: a systematic review and meta-analysis

  • All age groups
  • Measles
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Ong, D. S. Von Mollendorf, C. Mulholland, K. Do, L. A. H.

Measles Seroprevalence in Infants Under 9 Months of Age in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis

  • Newborn
  • Low and Middle Income Countries
  • Measles
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Fournais, L. A. Zimakoff, A. C. Jensen, A. Svanholm, J. H. Fosse, I. Stensballe, L. G.

Measles vaccines and non-specific effects on mortality or morbidity: A systematic review and meta-analysis

  • Newborn
  • Children
  • Adolescents
  • Measles
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Moderate
2025 ∙ Pargar, F. Rabiei, Z. Keramat, A.

Menstrual Disorders Following Covid 19 Vaccination in Women of Reproductive Age and Post-Menopause. A Systematic Review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Dorjee, K. Sadoff, R. C. Mansour, F. R. Dorjee, S. Binder, E. M. Stetson, M. Yuen, R. Kim, H.

Menstrual disturbance associated with COVID-19 vaccines: A comprehensive systematic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...